Utah Medical Products, Inc.
UTMD
$71.10
$0.390.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -2.21% | -3.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.21% | -3.57% | |||
| Cost of Revenue | 9.62% | -9.02% | |||
| Gross Profit | -9.92% | 0.34% | |||
| SG&A Expenses | -31.29% | -4.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.83% | -8.19% | |||
| Operating Income | 4.66% | 6.63% | |||
| Income Before Tax | 3.27% | 2.45% | |||
| Income Tax Expenses | 3.81% | 7.04% | |||
| Earnings from Continuing Operations | 3.15% | 1.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.15% | 1.48% | |||
| EBIT | 4.66% | 6.63% | |||
| EBITDA | -8.34% | 3.23% | |||
| EPS Basic | 3.19% | 1.88% | |||
| Normalized Basic EPS | 4.47% | 4.39% | |||
| EPS Diluted | 2.74% | 1.97% | |||
| Normalized Diluted EPS | 4.47% | 4.39% | |||
| Average Basic Shares Outstanding | -0.04% | -0.39% | |||
| Average Diluted Shares Outstanding | -0.04% | -0.39% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.03% | 0.00% | |||